The Need for a Coagulation Assay after Initiation of New Oral Anticoagulants in Patients with Renal Dysfunction: A Case Report.
CONCLUSIONS: The present case emphasizes the need for frequent checking of renal function and assessment using coagulation assays after commencing dabigatran therapy in patients with moderate-to-severe renal impairment.
PMID: 25749821 [PubMed - as supplied by publisher]
Source: Journal of Clinical Neurology - Category: Neurology Tags: J Clin Neurol Source Type: research
More News: Atrial Fibrillation | Bleeding | Brain | Coumadin | Gastroenterology | Laboratory Medicine | Men | Neurology | Pradaxa | Stroke | Warfarin